IBN SINA Pharmaceutical Industry Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares IBN SINA Pharmaceutical Industry Ltd with three other
pharmaceutical manufacturers in Asia:
Orchid Pharma Ltd
sales of 5.08 billion Indian Rupees [US$69.50 million]
YSP Southeast Asia Holding Bhd
(297.06 million Malaysian Ringgits [US$72.92 million]
Panacea Biotec Ltd
based in INDIA
(5.39 billion Indian Rupees [US$73.71 million]
of which 76%
IBN SINA Pharmaceutical Industry Ltd reported sales of 6.19 billion Bangladeshi Taka (US$74.30 million)
June of 2020.
increase of 17.6%
versus 2019, when the company's sales were 5.26 billion Bangladeshi Taka.
Sales at IBN SINA Pharmaceutical Industry Ltd have increased during each of the previous five years
(and since 2015, sales have increased a total of 96%).